Clinical Trials
566 trialsA Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
M.D. Anderson Cancer Center
VERDI
Dana-Farber Cancer Institute
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
Beth Israel Deaconess Medical Center
LEARN
University of Sydney
KCC-S
University of Utah
TTBF
University of California, San Francisco
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Brigham and Women's Hospital
Clinical Application of CAIX-Targeted PET Imaging in Tumors
Peking University Cancer Hospital & Institute
IRMK01
University Hospital, Bordeaux
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
CD70-targeted immunoPET Imaging of Malignant Cancers
RenJi Hospital
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
Advanced Diffusion Imaging in Renal Cancer Patients
NYU Langone Health
SLM + Axitinib for Clear Cell RCC
University of Iowa
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Vanderbilt-Ingram Cancer Center
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
University of Southern California
iCaRe2
University of Nebraska
NORDIC-SUN
University of Aarhus
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
LIAM Mc
University College Cork
FRISC
Centre Hospitalier Universitaire, Amiens
Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Emory University
COSTAR-002
Peking University First Hospital
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
BIOSUNTOX
University Hospital, Rouen
Rein3DP-M
University Hospital, Bordeaux
RCCETT
Peking University Third Hospital
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
SMART
University of Alberta
NEOPAX
University of Colorado, Denver
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Memorial Sloan Kettering Cancer Center
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
M.D. Anderson Cancer Center
NEPHRAMBU
GCS Ramsay Santé pour l'Enseignement et la Recherche
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Henry Ford Health System
PP-RECURK
Gødstrup Hospital
ORCHID
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SPARCC
Dana-Farber Cancer Institute
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
Chang Gung Memorial Hospital
NAMECAR
Institut Paoli-Calmettes
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Dana-Farber Cancer Institute
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Institut Paoli-Calmettes
KIDCaD
Charles University, Czech Republic
MetroWilms
Centre Oscar Lambret
64Cu-GRIP B in Patients With Advanced Malignancies
University of California, San Francisco
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
NeuroPrevPTSD
Centre Oscar Lambret